Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft

K-Number: K200064 · 2020-08-14

Decision Date2020-08-14
Product CodeMQV
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft is a medical device manufactured by SurGenTec, LLC. It received FDA 510(k) clearance on 2020-08-14 under approval number K200064. The device is classified under product code MQV. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft?

OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft is a medical device that received FDA 510(k) clearance on 2020-08-14. It is manufactured by SurGenTec, LLC. The 510(k) number is K200064.

When was OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft approved by the FDA?

OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft received FDA 510(k) clearance on 2020-08-14, under approval number K200064.

What company makes OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft?

OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft is manufactured by SurGenTec, LLC.

What is the FDA product code for OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft?

The FDA product code for OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft is MQV.

Related Clinical Trials

Other Devices by SurGenTec, LLC

View all 23 devices →

Related Devices (Code: MQV)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.